Security Snapshot

Ascendis Pharma A/S - COMMON STOCK (ASND) Institutional Ownership

CUSIP: K08588103

13F Institutional Holders and Ownership History from Q1 2026 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

176

Shares (Excl. Options)

19.74MFull value: 19,744,486 · shares · 30 Sep 2026

Price

$227.83

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / COMMON STOCK
Symbol
ASND on Nasdaq
All holders as of 30 Sep 2026
Q3 2026
Total 13F shares
19,744,486
Latest holder snapshot 5 signals
Total 13F value
$4,531,783,435
Portfolio coverage rank
0%
Share change
-1,093,767
Value change
-$277,151,734
Number of holders
176
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
65,884,490
SEC-reported price per share
$227.00
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ASND - Ascendis Pharma A/S - COMMON STOCK is tracked under CUSIP K08588103.
  • 176 institutions reported positions in Q3 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 304 to 176 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $17.7BFull value: $17,698,610,895 · USD · 30 Jun 2026
    to
    $4.53BFull value: $4,531,783,435 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 176 institutions filings for Q3 2026.

Open SEC evidence

Security key

K08588103

13F reference period

Q3 2026

13F holders

176

13D/G owners

2

CIK / CUSIP context first

Open Q3 2026 holders ASND full holder history Ascendis Pharma A/S SEC filings Ascendis Pharma A/S company facts Ascendis Pharma A/S insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
ASND
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 5.2% $777,700,520 3,425,993 FMR LLC 30 Sep 2026
Artisan Partners Limited Partnership 4.2% $698,595,845 2,634,024 Artisan Partners Asset Management Inc. 30 Jun 2026
As of 30 Sep 2026, 176 institutional investors reported holding
19.74MFull value: 19,744,486 · shares · 30 Sep 2026
shares of Ascendis Pharma A/S - COMMON STOCK (ASND). This represents 30% of the company’s total
65.88MFull value: 65,884,490 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
28%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WESTFIELD CAPITAL MANAGEMENT CO LP 7.8% 5,125,027 +6.8% 3.8% $1,167,634,813
Artisan Partners Limited Partnership 3.2% 2,083,019 -21% 0.87% $474,581,269
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.9% 1,896,095 +1.1% 0.16% $431,925,066
Capital International Investors 2.2% 1,417,389 -29% 0.07% $322,923,736
AMERICAN CENTURY COMPANIES INC 1.9% 1,251,360 -11% 0.12% $285,099,019
FRANKLIN TEMPLETON INC 1.7% 1,108,296 -40% 0.06% $285,862,787
Capital World Investors 1.4% 908,029 +0.21% 0.03% $206,876,210
STATE STREET CORP 0.9% 590,220 +15% 0% $134,469,823
MORGAN STANLEY 0.7% 460,564 -15% 0.01% $104,930,603
GEODE CAPITAL MANAGEMENT, LLC 0.64% 423,254 +5% 0.01% $96,429,958
Chevy Chase Trust Holdings, LLC 0.55% 363,640 0.2% $82,848,102
FIL Ltd 0.54% 355,243 +2.8% 0.06% $80,935,013
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.34% 221,107 +76% 0.02% $50,374,808
ARS Investment Partners, LLC 0.31% 206,179 -2% 2.1% $46,973,762
NEUBERGER BERMAN GROUP LLC 0.31% 202,559 0.03% $46,149,017
Empowered Funds, LLC 0.29% 188,229 +0.51% 0.2% $42,884,213
USS Investment Management Ltd 0.26% 170,587 +21% 0.15% $38,877,630
Invesco Ltd. 0.25% 163,078 -61% 0% $37,154,062
BNP PARIBAS FINANCIAL MARKETS 0.23% 152,455 0.02% $34,733,823
SILVERARC CAPITAL MANAGEMENT, LLC 0.23% 152,175 -26% 4.2% $34,670,030
Spyglass Capital Management LLC 0.23% 151,549 -30% 2% $34,527,409
Fiera Capital Corp 0.22% 146,955 +42% 0.13% $33,480,758
VANGUARD PORTFOLIO MANAGEMENT LLC 0.21% 135,514 +31% 0% $30,874,155
BRAUN STACEY ASSOCIATES INC 0.2% 133,224 +0.41% 0.87% $30,352,424
Siren, L.L.C. 0.2% 130,000 0.7% $29,617,900

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
3
Headline period
Q3 2026
Rows shown
1-3 of 3
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 19,744,486 $4,531,783,435 -$277,151,734 $227.83 176
2026 Q2 66,359,558 $17,698,610,895 +$14,560,815,957 $266.72 304
2026 Q1 7,936,554 $1,815,328,317 +$1,815,328,317 $228.73 8
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .